Birdwatch Note
2024-01-30 05:09:15 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
上海、オックスフォード、ルワンダ、ケニヤ、豪州メルボルンなどでmRNAワクチン工場の建設や計画が進められています。 https://jp.reuters.com/markets/global-markets/KPRPX34JT5MSNMGJOMM3HROLKI-2023-11-28/ https://www.europeanpharmaceuticalreview.com/news/181939/modernas-mrna-vaccine-manufacturing-centre-begins-construction/ https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-aims-start-mrna-vaccine-output-rwanda-2025-2023-12-18/ https://prtimes.jp/main/html/rd/p/000000097.000064549.html https://www.industry.gov.au/news/mrna-vaccine-manufacturing-facility-commences-construction-melbourne
Written by D6F1DDC837F7C9A02C54B473C6052E4A8E54C564151A11A3A1B4B41D297BF8C7
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1751962244970365134
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1752197259402621271
- noteId - 1752197259402621271
- participantId -
- noteAuthorParticipantId - D6F1DDC837F7C9A02C54B473C6052E4A8E54C564151A11A3A1B4B41D297BF8C7 Participant Details
- createdAtMillis - 1706591355549
- tweetId - 1751962244970365134
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 上海、オックスフォード、ルワンダ、ケニヤ、豪州メルボルンなどでmRNAワクチン工場の建設や計画が進められています。 https://jp.reuters.com/markets/global-markets/KPRPX34JT5MSNMGJOMM3HROLKI-2023-11-28/ https://www.europeanpharmaceuticalreview.com/news/181939/modernas-mrna-vaccine-manufacturing-centre-begins-construction/ https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-aims-start-mrna-vaccine-output-rwanda-2025-2023-12-18/ https://prtimes.jp/main/html/rd/p/000000097.000064549.html https://www.industry.gov.au/news/mrna-vaccine-manufacturing-facility-commences-construction-melbourne
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-01-30 05:09:15 UTC (1706591355549) |
2024-01-30 13:06:44 UTC (1706620004861) |
CURRENTLY_RATED_HELPFUL | 2024-01-31 02:06:08 UTC (1706666768602) |
CURRENTLY_RATED_HELPFUL | 2024-01-30 13:06:44 UTC (1706620004861) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-01-30 18:20:54 -0600 | Rating Details | |
| 2024-01-30 17:42:03 -0600 | Rating Details | |
| 2024-01-30 16:54:13 -0600 | Rating Details | |
| 2024-01-30 16:51:15 -0600 | Rating Details | |
| 2024-01-30 16:49:26 -0600 | Rating Details | |
| 2024-01-30 16:45:36 -0600 | Rating Details | |
| 2024-01-30 16:41:23 -0600 | Rating Details | |
| 2024-01-30 16:38:04 -0600 | Rating Details | |
| 2024-01-30 16:33:32 -0600 | Rating Details | |
| 2024-01-30 15:50:09 -0600 | Rating Details | |
| 2024-01-30 13:11:54 -0600 | Rating Details | |
| 2024-01-30 08:08:03 -0600 | Rating Details | |
| 2024-01-30 07:38:13 -0600 | Rating Details | |
| 2024-01-30 04:14:27 -0600 | Rating Details | |
| 2024-01-30 03:47:02 -0600 | Rating Details | |
| 2024-01-30 03:00:13 -0600 | Rating Details | |
| 2024-01-30 02:24:13 -0600 | Rating Details | |
| 2024-01-30 01:40:13 -0600 | Rating Details | |
| 2024-01-30 01:35:23 -0600 | Rating Details | |
| 2024-01-30 00:45:40 -0600 | Rating Details | |
| 2024-01-30 00:40:08 -0600 | Rating Details | |
| 2024-01-30 00:18:41 -0600 | Rating Details | |
| 2024-01-30 00:16:45 -0600 | Rating Details | |
| 2024-01-30 00:15:30 -0600 | Rating Details | |
| 2024-01-30 00:01:18 -0600 | Rating Details | |
| 2024-01-29 23:59:08 -0600 | Rating Details | |
| 2024-01-29 23:59:00 -0600 | Rating Details | |
| 2024-01-29 23:52:59 -0600 | Rating Details | |
| 2024-01-29 23:40:52 -0600 | Rating Details | |
| 2024-01-29 23:39:26 -0600 | Rating Details | |
| 2024-01-29 23:36:57 -0600 | Rating Details | |
| 2024-01-29 23:28:14 -0600 | Rating Details | |
| 2024-01-29 23:23:39 -0600 | Rating Details | |
| 2024-01-29 23:12:32 -0600 | Rating Details | |
| 2024-01-31 15:52:50 -0600 | Rating Details | |
| 2024-01-31 03:36:39 -0600 | Rating Details | |
| 2024-01-31 01:55:40 -0600 | Rating Details | |
| 2024-01-30 19:09:04 -0600 | Rating Details | |
| 2024-01-30 19:08:06 -0600 | Rating Details | |
| 2024-01-31 21:47:30 -0600 | Rating Details | |
| 2024-02-01 00:22:15 -0600 | Rating Details | |
| 2024-01-30 21:09:22 -0600 | Rating Details | |
| 2024-01-30 21:06:07 -0600 | Rating Details | |
| 2024-01-30 18:38:05 -0600 | Rating Details | |
| 2024-01-30 18:18:50 -0600 | Rating Details | |
| 2024-01-30 18:07:56 -0600 | Rating Details | |
| 2024-01-30 17:26:21 -0600 | Rating Details | |
| 2024-01-30 17:12:34 -0600 | Rating Details | |
| 2024-01-30 16:28:37 -0600 | Rating Details | |
| 2024-01-30 06:06:54 -0600 | Rating Details | |
| 2024-01-30 02:14:00 -0600 | Rating Details | |
| 2024-01-30 00:43:13 -0600 | Rating Details | |
| 2024-01-30 00:22:21 -0600 | Rating Details | |
| 2024-01-30 00:15:58 -0600 | Rating Details | |
| 2024-01-30 00:07:12 -0600 | Rating Details | |
| 2024-01-30 00:05:14 -0600 | Rating Details | |
| 2024-01-30 00:04:06 -0600 | Rating Details | |
| 2024-01-30 00:03:05 -0600 | Rating Details | |
| 2024-01-29 23:44:39 -0600 | Rating Details | |
| 2024-01-29 23:42:08 -0600 | Rating Details | |
| 2024-01-29 23:39:32 -0600 | Rating Details | |
| 2024-01-29 23:38:28 -0600 | Rating Details |